Craft

Johnson & Johnson

Stock Price

$145.6

2024-06-18

Market Capitalization

$350.3 B

2024-06-15

Revenue

$85.2 B

FY, 2023

Johnson & Johnson Summary

Company Summary

Overview
Johnson & Johnson (J&J) is a company that engages in the research and development, manufacture, and sale of a range of products in the healthcare field. It operates through three business segments: Consumer Health, Pharmaceutical, and MedTech. The Consumer Health segment includes personal healthcare products used in baby care, oral care, beauty, women’s health, wound care, and other markets. The Pharmaceutical segment is focused on the therapeutic areas of immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism as well as pulmonary hypertension. The MedTech segment offers products used in the interventional solutions, orthopedics, surgery, and vision fields.
Type
Public
Status
Active
Founded
1886
HQ
New Brunswick, NJ, US | view all locations
Website
https://www.jnj.com
Cybersecurity rating
ESG rating
60-79 out of 100|View all ESG data
Sectors

Key People

  • Joaquin Duato

    Joaquin Duato, Chairman and Chief Executive Officer

  • Joseph J. Wolk

    Joseph J. Wolk, Executive Vice President, Chief Financial Officer

  • Peter Fasolo

    Peter Fasolo, Executive Vice President, Chief Human Resources Officer

  • Kathryn E. Wengel

    Kathryn E. Wengel, Executive Vice President, Chief Technical Operations & Risk Officer

Operating MetricsView all

Manufacturing Space, sq. ft.

14.9M

FY, 2022

Manufacturing Facilities (Europe)

27
8.0%

FY, 2022

Manufacturing Facilities (United States)

28
7.7%

FY, 2022

LocationsView all

79 locations detected

  • New Brunswick, NJ HQ

    United States

    1 Johnson And Johnson Plaza

  • Jacksonville, FL

    United States

    7500 Centurion Pkwy N

  • Lancaster, PA

    United States

    1838 Colonial Village Ln

  • Piscataway, NJ

    United States

    425 NJ-18

  • Buenos Aires, Buenos Aires

    Argentina

    Mendoza 1259

  • Sydney, NSW

    Australia

    1-5 Khartoum Rd

and 73 others

Johnson & Johnson Financials

Summary Financials

Revenue (Q1, 2024)
$21.4B
Gross profit (Q1, 2024)
$14.9B
Net income (Q1, 2024)
$3.3B
Cash (Q1, 2024)
$25.5B
EBIT (Q1, 2024)
$3.3B
Enterprise value
$358.4B

Footer menu